Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
149.85
-8.33 (-5.27%)
At close: Jul 15, 2025, 4:00 PM
149.85
0.00 (0.00%)
After-hours: Jul 15, 2025, 5:11 PM EDT
Natera Market Cap
Natera has a market cap or net worth of $20.46 billion as of July 15, 2025. Its market cap has increased by 49.58% in one year.
Market Cap
20.46B
Enterprise Value
19.75B
1-Year Change
49.58%
Ranking
Category
Stock Price
$149.85
Market Cap Chart
Since July 2, 2015, Natera's market cap has increased from $1.10B to $20.46B, an increase of 1,758.11%. That is a compound annual growth rate of 33.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 21.60B | 3.35% |
| Dec 31, 2024 | 20.90B | 177.68% |
| Dec 29, 2023 | 7.53B | 91.96% |
| Dec 30, 2022 | 3.92B | -55.62% |
| Dec 31, 2021 | 8.83B | 3.98% |
| Dec 31, 2020 | 8.50B | 225.28% |
| Dec 31, 2019 | 2.61B | 202.62% |
| Dec 31, 2018 | 863.10M | 78.55% |
| Dec 29, 2017 | 483.40M | -21.19% |
| Dec 30, 2016 | 613.40M | 13.59% |
| Dec 31, 2015 | 540.00M | -50.96% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 715.10B |
| Johnson & Johnson | 376.91B |
| AbbVie | 338.05B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 272.69B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 230.70B |
| AstraZeneca | 218.74B |